|Bid||0.3675 x 0|
|Ask||0.4140 x 0|
|Day's Range||0.3720 - 0.4150|
|52 Week Range||0.0128 - 1.6400|
|Beta (5Y Monthly)||3.57|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER BC / ACCESSWIRE / May 17, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FRANKFURT:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") is providing an update with respect to its previously announced management cease trade order (the "MCTO") issued by the British Columbia Securities Commission on May 3, 2021.
COVID-19 testing provided by Empower subsidiary Kai Medical LaboratoryVANCOUVER BC / ACCESSWIRE / May 11, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce pursuant to a Referral Agreement dated May 10, 2021 that a major Canadian airline will now refer its passengers to Kai Care for expedited COVID-19 testing.